Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
Lung | Lung Cancer

Lung Cancer Drug, Osimertinib, Drastically Reduces Death Risk after Surgery

Posted on June 12, 2023
Post Views: 379

Lung | Lung CancerLung cancer is among most common types of cancers in U.S. as well as around the world. According to the Centers for Disease Control and Prevention, it is responsible for nearly a quarter of U.S. cancer deaths in the year 2020. According to the new trial findings, taking Tagrisso, also known as Osimertinib, a once-daily medication, after removal of tumor via surgery reduces risk of people dying from cancer by 51%. The research is published recently in The New England Journal of Medicine.

In the trial, 682 patients were included with the mutation called T790M. About half of them took Osimertinib once a day while others took a placebo bill. These participants had surgically removed tumor and their cancers were at stage 1 2 or 3. Some of them had also completed chemotherapy treatments. The patients took the medicine and they were monitored for a median of five years. After the time period of five years 88% of those patients with Osimertinib remained alive as compared with 78% of the control population. This implies that the drug halved the risk of death during that five-year span. Also, the medicine was also to reduce disease recurrence as well.  The patients in trial with more advanced level of cancer, 85% of those on Osimertinib survived after five years in comparison with 67% of those who took placebo.

This new study has shown evidence that same drug can improve outcomes along lung cancer patients with earlier stages. Deputy director of the Yale Cancer Center and lead author of the paper, Roy Herbst, said, “It’s really taking personalized therapy from advanced metastatic disease and moving it all the way to the earliest stages of lung cancer treatment.”

The information shared in this blog is for educational purposes only. You should always consult your healthcare practitioner for any medical needs.

Subscribe to our newsletter or follow us on Facebook or Twitter today and never miss out an update!

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Telegram (Opens in new window) Telegram

Like this:

Like Loading...

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (7,322)
  • Lung Cancer: Symptoms and Treatment (5,653)
  • What is Non-Small-Cell Lung Cancer? (5,551)

Recent Comments

  • Lung Cancer on New Study To Help Advance Research In Lung Cancer
  • Laurie B Grimes on New Study To Help Advance Research In Lung Cancer
  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?

Recent Articles

  • Predicting Lung Cancer Risk with AI based Deep Learning Model May 26, 2025
  • FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC May 19, 2025
  • Heart-Sparing Technique in Lung Cancer Radiotherapy May 12, 2025
  • Origins of Common Lung Cancer Linked to Smoking Discovered May 5, 2025
  • Lung Cancer Screening Is Beneficial For Non-Smokers As Well April 28, 2025

Lung Cancer Blog

Lung Cancer Blog provides all lung cancer related information for educational purposes.

Disclaimer

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

If you have any query or suggestions about our blog, please feel free to email us at  lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2025 Lung Cancer Blog. Wordpress by Vipasha.
  • Privacy Policy
  • About Us
  • Sitemap
  • Contact Us
%d